Mechanism‐guided mutagenesis of Rft1 to test its role as a dolichol‐linked oligosaccharide scramblase in cells
Protein Science · 2026-08 · 35 (8)
DOI: 10.1002/pro.70715 ↗At a glance
Journal article in Protein Science, published online on 2026-07-08. Written by George N Chiduza and 4 co-authors. Institution: Biochemistry and Structural Biology-Chemistry Department, Université Libre de Bruxelles-Campus Plaine, Brussels, Belgium. Major MEDLINE topics: Dolichols, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Oligosaccharides. Cited 2 times so far (Crossref); 75 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, Fonds De La Recherche Scientifique - FNRS, NIH HHS.
Abstract (original language)
The membrane protein Rft1 is proposed to play an essential role in yeast and human cells by scrambling the glycolipid Man5GlcNAc2‐PP‐dolichol (M5‐DLO) across the endoplasmic reticulum (ER) for protein N ‐glycosylation. While this activity has been demonstrated in liposomes reconstituted with purified Rft1, biochemical evidence of additional M5‐DLO scramblases and the viability of Rft1‐null Trypanosoma brucei suggest that scrambling may be a moonlighting function of Rft1 rather than its essential cellular role. To investigate this problem, we used AlphaFold3 and Chai‐1 to model the conformational dynamics of yeast Rft1‐M5‐DLO complexes. The models suggest an alternating access mechanism, typical of Multidrug/Oligosaccharidyl‐lipid/Polysaccharide (MOP) superfamily transporters, in which a cationic central cavity coordinates the anionic headgroup of M5‐DLO, while the dolichol tail of the lipid is accommodated through a lateral portal formed by two transmembrane helices. We used the models to design mutations to disrupt the interaction between Rft1 and the M5‐DLO headgroup, and to engineer a salt bridge to block the portal and stall transport. Using a Tet‐off yeast reporter strain, we tested 26 central cavity mutants and identified 2 that supported cell growth poorly despite being well‐expressed. Strikingly, the portal‐blocking mutant which is predicted to lack scramblase activity supported robust growth. These data suggest that while M5‐DLO binding is important for Rft1's essential function, scrambling activity is dispensable. We speculate that Rft1's essential role may be as an M5‐DLO chaperone, capturing and routing M5‐DLO propitiously on the cytoplasmic side of the ER to coordinate DLO biosynthesis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Biochemistry and Structural Biology-Chemistry Department, Université Libre de Bruxelles-Campus Plaine, Brussels, Belgium.
- Department of Biochemistry and Biophysics, Weill Cornell Medical College, New York, New York, USA.
ORCID profiles: George N Chiduza
Funding
- NIGMS NIH HHS
- Fonds De La Recherche Scientifique - FNRS
- NIH HHS
- National Institutes of Health
Cite
APA
Chiduza, G. N., Sakata, K. T., Wolfe, H. G., Noor, F., & Menon, A. K. (2026). Mechanism‐guided mutagenesis of Rft1 to test its role as a dolichol‐linked oligosaccharide scramblase in cells. Protein Science, 35(8). https://doi.org/10.1002/pro.70715
Vancouver
Chiduza GN, Sakata KT, Wolfe HG, Noor F, Menon AK. Mechanism‐guided mutagenesis of Rft1 to test its role as a dolichol‐linked oligosaccharide scramblase in cells. Protein Science. 2026;35(8). doi:10.1002/pro.70715
BibTeX
@article{Chiduza2026,
author = {Chiduza, George N and Sakata, Ken-Taro and Wolfe, Hannah G and Noor, Faria and Menon, Anant K},
title = {Mechanism‐guided mutagenesis of Rft1 to test its role as a dolichol‐linked oligosaccharide scramblase in cells},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {8},
doi = {10.1002/pro.70715}
}
EUVIMED